In recent years, the home-use medical device market has entered a period of rapid development. According to data from Eshare (医械汇), the market size of home-use medical devices in 2024 reached RMB 262.4 billion (approximately USD 36.1 billion), marking a year-on-year growth of 12.0%. This segment’s share within China’s overall medical device market has further risen to 24.7%! In the post-pandemic era, how have home-use medical devices emerged as a high-growth niche? How should we understand the new driving forces of category and sales growth to gain a head start in market competition?
Market Size Analysis of Home-Use Medical Devices
With continued release of policy dividends, an aging population, and heightened public health awareness, China’s home-use medical device market has demonstrated sustained and rapid growth. Data from Eshare shows a compound annual growth rate (CAGR) of ~15% from 2020 to 2024, and its share in the overall market has continued to increase.
Policy dividends have become the primary driving force in the industry. The Healthy China 2030 Planning Outline explicitly proposes “shifting the focus of healthcare services from treatment-centered to health-centered” and encourages the widespread use of household health equipment. The 14th Five-Year Plan for the Development of the Medical Equipment Industry mentions the development of home and community-level new medical equipment, integrating health-sensing devices in living areas for key groups such as the elderly and those with chronic diseases. Medical scenarios are gradually expanding from hospitals to homes, driving rapid growth in the home-use medical device market.
Population aging and the “silver economy” are generating rigid demand. In 2024, the proportion of the population aged 60 and over in China surpassed 20%, further intensifying aging trends. The General Office of the State Council issued the Opinions on Developing the Silver Economy and Enhancing the Well-being of the Elderly, which for the first time elevated the “silver economy” to a national strategy. It encourages the development of products for the elderly with chronic diseases, including home-use diagnostic, monitoring, and rehabilitation equipment, thereby expanding market size.
End-user health awareness has improved. In the post-pandemic era, public health consciousness has clearly risen. Health management is expanding toward personal daily care. Usage scenarios have diversified—from traditional disease monitoring to health management, disease prevention, and rehabilitation care. Changes in consumer demographics are also prompting upstream manufacturers to invest more in R&D and product optimization.
Looking at specific subcategories, because the industry encompasses a wide range of fragmented products, various types of therapy devices, training equipment, and hygiene care products account for more than 50% of the market. According to BCC expert interviews, key category performance in 2024 is as follows:
| Category | Market Size (RMB bn) | YoY Growth |
| Glucose Monitors | ~9.0 billion (~USD 1.24B) | ~12% |
| Blood Pressure Monitors | ~9.0 billion (~USD 1.24B) | ~10% |
| Home Oxygen Concentrators | 10–12 billion (USD 1.38B–1.66B) | 12–15% |
| Home-use Ventilators | ~3.0 billion (~USD 0.41B) | 12–15% |
| Uric Acid Monitors | ~1.0 billion (~USD 0.14B) | 15–20% |
New product categories are becoming the core growth driver. Continuous Glucose Monitoring (CGM) is a prime example. It uses glucose sensors to monitor glucose concentrations in interstitial fluid under the skin and calculates blood glucose levels via algorithms. Compared to traditional Blood Glucose Meters (BGM), CGMs avoid the risks and pain of fingertip pricks while providing continuous daily readings and glucose fluctuation trends. This offers warning functions and helps patients better manage glucose levels, making it one of the fastest-growing categories.
Competitive Landscape of the Home-Use Medical Device Market
The market presents a diversified competitive landscape with both international and domestic brands actively participating. Since the entry threshold for home-use medical devices is relatively low, the number of domestic players is large, forming a fully competitive market. Domestic manufacturers are gradually making inroads into the high-end sector, increasing their market share.
Taking CGM as an example, Abbott, the “pioneer” of this category, currently holds over 20% market share. However, domestic brands are improving their competitiveness through pricing strategies (e.g., Abbott’s first-gen product costs RMB 300–400/month or USD 41–55/month, while domestic brands cost less than half) and functional/product experience enhancements (e.g., using Bluetooth instead of NFC for data transmission, extending monitoring duration). Leading domestic brands such as Yuwell (鱼跃医疗) and SiliconMotion (硅基动感) have each captured ~20% of the CGM market.
On the other hand, leading domestic companies are showing diversified business models. Many listed companies have reported sustained revenue growth or achieved recovery in the first half of 2025, solidifying their market position.
Future Trends in Home-Use Medical Devices: E-Commerce, Services, and Going Global
Overall, the Chinese home-use medical device market is expected to maintain growth of over 10%. Key trends include:
1. E-commerce channels becoming increasingly influential.
According to data from the National Medical Products Administration, from 2018 to May 2025, the number of companies engaged in online sales of medical devices rose from 8,717 to over 360,000. The number of third-party platform enterprises increased from 77 to 851. Interest-based e-commerce platforms have rapidly emerged, integrating medical education with product sales, restructuring consumer scenarios, and effectively stimulating health-related demand.
Data from Shanglin Library (商霖文库) shows that leading companies like Cofoe (可孚医疗) plan to significantly increase their livestreaming ad budgets in 2025—accounting for over 30% of total ad spend—with Douyin (TikTok China), Kuaishou, and Xiaohongshu (RED) as major platforms. Online sales ratios for leading domestic brands continue to rise:
- Yuwell: >35% online sales
- Cofoe: >50%
- Sinocare (三诺生物): ~30%
The rapid development of online channels is due to three main reasons:
(a) Chinese consumers are digitally savvy and used to comparing and purchasing via e-commerce platforms;
(b) Online platforms offer massive traffic and wide coverage, enabling brand and promo-driven consumption;
(c) Public + private traffic channels are developing in parallel, and interest-based e-commerce is further penetrating the home medical device market.
2. The “device + service” model is becoming increasingly refined.
On one hand, expectations for immediacy—from product selection and ordering to delivery—have increased. JD Health, for example, uses big data to forecast demand and pre-distributes products to regional front warehouses, with dedicated couriers making last-mile deliveries, greatly shortening delivery times. On the other hand, brands offering integrated solutions (device usage, consumable replenishment, health guidance) can better increase consumer goodwill and retention.
3. Going global becomes a new growth engine.
Facing domestic market saturation and increased competition, leading domestic brands are targeting Southeast Asia and Latin America as strategic markets. For example, Yuwell’s 2025 international sales target is RMB 1 billion (~USD 138 million), up 50% YoY. Sinocare’s international growth target also exceeds 25%. Leveraging cost-effectiveness and products tailored to local needs, Chinese brands are replicating their domestic success abroad and gradually establishing international brand presence.
[Disclaimer]: The above content reflects analysis of publicly available information, expert insights, and BCC research. It does not constitute investment advice. BCC is not responsible for any losses resulting from reliance on the views expressed herein. Investors should exercise caution.